CDH5 and infarction: This approach will enable the use of VE-Cadherin, an endothelial marker with high specificity even in infarction, to reconstruct microvessels and it will allow the simultaneous study of endothelial junctions, SMA+ and microvessels through the use of two fluorescent markers (VE-Cadherin, SMA+ cells) instead of three.